Bivalent ligands for the treatment of neurological disorders
Abstract:
Bivalent ligands that contain two pharmacophores linked through a spacer, one of which interacts with the μ-opioid receptor (MOR) and the other of which interacts with the co-receptor CC chemokine receptor 5 (CCR5), are used for the treatment of neurological disorders such as those associated with AIDS.
Public/Granted literature
Information query
Patent Agency Ranking
0/0